- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Deterioration of Glycemic Control during Octreotide LAR Treatment in an Acromegalic Japanese Patient with Type 2 Diabetes Mellitus
-
- KAHARA Toshio
- Department of Internal Medicine, Toyama Prefectural Central Hospital
-
- UENO Keiko
- Department of Internal Medicine, Toyama Prefectural Central Hospital
-
- TORITA Muneyoshi
- Department of Internal Medicine, Toyama Prefectural Central Hospital
-
- USUDA Rika
- Department of Internal Medicine, Toyama Prefectural Central Hospital
-
- ABE Takumi
- Department of Neurosurgery, Showa University School of Medicine
Search this article
Description
We report a case showing deterioration of glycemic control during octreotide long-acting release (LAR) treatment in an acromegalic Japanese patient with type 2 diabetes mellitus. The patient did not show much improvement of insulin sensitivity (QUICKI; 0.33 before treatment, 0.35 during octreotide LAR treatment), and showed a significant reduction in early insulin secretion (insulinogenic index; 0.28 before treatment, 0.08 during octreotide LAR treatment) on 75 g oral glucose tolerance test (75gOGTT), despite decreases in GH and IGF-I levels during the course of octreotide LAR treatment. Postoperatively, both insulin sensitivity and early insulin secretion on 75gOGTT were improved (QUICKI 0.59, insulinogenic index 0.35). There are some reports that insulinogenic index is lower in most Japanese patients with type 2 diabetes mellitus and that early insulin secretions are significantly suppressed after administration of octreotide LAR. Although the influence of octreotide LAR on glucose metabolism varies among individuals, it is necessary to manage the deterioration of glucose tolerance during octreotide LAR treatment in acromegalic Japanese patients with decreased insulinogenic index.<br>
Journal
-
- Endocrine Journal
-
Endocrine Journal 54 (2), 329-333, 2007
The Japan Endocrine Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390282681274125952
-
- NII Article ID
- 10019478929
- 130004443299
-
- NII Book ID
- AA10901436
-
- ISSN
- 13484540
- 09188959
-
- PubMed
- 17339747
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed